/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Care N’ Care Health Plan Partners with Industry’s Leading Companies to Positively Impact Members’ Health and Well-Being
Innovative R.E.A.C.H. Program Provides Members with Chronic
Conditions the Additional Support and Resources They Need to Better
Manage Their Health
FORT WORTH, Texas–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/REACH?src=hash” target=”_blank”gt;#REACHlt;/agt;–Care N’ Care (HMO/PPO) Health Plan announced today the launch of a new
program designed to provide members with chronic conditions the
additional support they need to manage their health and maintain active
and fulfilling lives.
Under the new “Resources for Enhanced Access to Community Health”
program—or R.E.A.C.H.—Care N’ Care is assembling some of the nation’s
best-known and most widely respected healthcare companies to provide
value-added services and resources to Care N’ Care members. When fully
amassed, these industry leaders will provide everything from on-demand
medical care at home, behavioral health, and home healthcare to
radiology services, advanced illness decision support, palliative care
and much more.
“The creation of R.E.A.C.H. is part of our continued focus of looking
for new and better ways to positively impact a member’s health and
well-being and to remind members of the importance of consistent
self-care so they can live life to its fullest,” said Care N’ Care Chief
Medical Officer David J. Sand, M.D. “The clinical partners we are
assembling under this unique program all share our philosophy and
mission and, as trusted partners, greatly expand the scope of supportive
member services we are able to offer.”
Charter partners in R.E.A.C.H. include:
-
AdhereHealth – A leading healthcare technology company focused
on medication adherence, AdhereHealth will help Care N’ Care members
better manage their medications. Using data analytics, AdhereHealth
will identify individuals who may not be taking their medications and
work directly with members and their doctors to resolve adherence
challenges. Assistance may take the form of regular medication reviews
with licensed clinicians, synchronizing the delivery of multiple
medications directly to members’ homes, coordinating transportation to
the doctor or pharmacy, and addressing the high cost of medications
and other barriers to care. -
Medtronic Care Management Services – As part of one of
the largest medical technology, services and solutions companies in
the world, Medtronic Care Management Services will provide at-home
daily health checks and clinical monitoring for members as Care N’
Care’s Connected Health program. Remote patient monitoring can
play a role in impacting the health of members with common chronic
health conditions, including congestive heart failure, chronic
obstructive pulmonary disease, diabetes, coronary artery disease and
high blood pressure by delivering insights to help address patients’
unmet needs at home and intervene before an acute event. -
Turn-Key Health – Recognized nationwide for providing
exceptional community-based palliative care solutions to health plans,
provider organizations and their members, Turn-Key will support Care
N’ Care members and their caregivers with its Palliative Illness
Management® solution. This home-based program improves
symptom management, establishes goals of care, promotes shared
decision-making, and reduces unplanned and non-beneficial healthcare.
Going beyond traditional care coordination to also address social
determinants of health results in better patient-centered care plans. -
Vital Decisions – The leading organization in advance care
planning and alignment for members with serious illness, Vital
Decisions will provide Care N’ Care members and their families
personalized support with medical decision-making. The telehealth
program Living Well is delivered over the phone or video session by
specialists trained in healthcare decision-making and counseling. The
program is offered over multiple sessions. The goal is to ensure that
an individual dealing with a complex medical situation has a process
for considering how their unique values and wishes are understood,
communicated and ultimately reflected in their healthcare. Further, in
the event of a medical emergency, others are equipped to make sure
that care that is delivered is aligned with the member’s wishes.
Advance care planning documents are also made available as part of
this process.
“This new era of collaborative partnership is designed for those Care N’
Care members who need additional support confronting challenging
healthcare issues,” said Dr. Sand. “Our goal is to go beyond the
historical role that health plans have played and instead be much more
proactive in truly being the member’s healthcare partner in providing
resources, education and solutions when they need them most.”
Care N’ Care is a Medicare Advantage health plan providing North Texas
Medicare beneficiaries in Tarrant, Johnson, Dallas, Collin, Denton,
Rockwall, Hood, Wise and Parker counties affordable alternatives that
improve and simplify Medicare coverage. With both PPO and HMO health
plans, Care N’ Care offers all of the traditional benefits included in
original Medicare plus additional benefits and services, including a
personal Healthcare Concierge to serve as the single point of contact
and trusted partner throughout the member’s healthcare experience. For
more information about Care N’ Care and its Medicare Advantage health
plans, visit cnchealthplan.com.
Contacts
Ross Goldberg
[email protected]
818-597-8453,
x-1
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE5 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III